艾昆纬 IQV 深 沪
等待开盘 08-17 09:30:00 美东时间
236.66
-4.860
-2.01%
华盛通- 最 高243.00
- 今 开240.55
- 成交量 90.56万股
- 最 低 235.865
- 昨 收 241.52
- 总市值 3895.42万
- 52周最高 251.36
- 市盈率 静 30.19
- 换手率 550.19%
- 52周最低 154.50
- 委 比 29.87%
- 总股本 0.00亿
- 历史最高 285.61
- 量 比 0.92
- 振 幅 2.95%
- 历史最低 81.79
- 每 手 1
- 风险率 25.22%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Legend Biotech downgraded at Oppenheimer on CEO exit, competition
Legend Biotech (LGND) shares fell on Wednesday after Oppenheimer downgraded the cell therapy developer to Perform from Outperform, citing the recent departure of its CEO, competitive headwinds, and di...
08-12 23:17
SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray
Scienture Holdings, Inc. announced the commercial launch of REZENOPY™ (naloxone hydrochloride) Nasal Spray 10 mg, the highest-dose FDA-approved naloxone hydrochloride nasal spray in the U.S., designed for emergency treatment of opioid overdose. The launch includes a dedicated national sales team, payer coverage reaching over 100 million lives, and GPO agreements with over 5,000 healthcare facilities, targeting the $143 million U.S. naloxone marke...
08-12 12:05
解码致病通路 加快研发突破
（来源：中国医药报） 转自：中国医药报 近年来，与中枢神经系统（CNS）疾病相关的全球疾病负担持续上升，造成巨大的经济影响。预计到2030年，仅心理健康问题造...
08-06 07:59
Eli Lilly's obesity momentum faces another earnings test
Eli Lilly (NYSE: LLY) is scheduled to report second-quarter results before the market opens on Wednesday, Aug. 5, with investors looking for another strong quarter driven by continued demand for its b...
08-04 23:46
July healthcare recap: Regeneron, DexCom shine as Moderna, managed-care stocks retreat
The healthcare sector (XLV) gained about 2.45% in July, outperforming the broader S&P 500 (SPY), which slipped around 0.12% during the month. Company-specific earnings and catalysts drove stock perfor...
08-01 23:05
美股大行评级 | 最高1400美元！花旗、大小摩8家大行上调希捷科技目标价；大行集中调整目标价：康宁、科斯塔、思佳讯遭下调，PayPal、Visa、可口可乐、赛莱默获上调
今日重点评级关注：古根海姆：维持ProMIS Neurosciences"买入"评级，目标价从35美元升至69美元；BTIG：维持Cullinan Therapeutics"买入"评级，目标价从38美元升至39美元
07-30 11:45
财报速睇 | 艾昆纬 2026财年Q2营收43.68亿美元，同比增长8.7%；归母净利润2.56亿美元，同比下滑3.8%
华盛资讯7月29日讯，艾昆纬公布2026财年Q2业绩，公司Q2营收43.68亿美元，同比增长8.7%，归母净利润2.56亿美元，同比下滑3.8%。
07-29 04:50
ICON plc rises after Anthropic deal, Iqvia earnings
ICON plc (ICLR) traded higher after the Irish contract research organization announced a partnership with Anthropic (ANTHRO) amid peer IQVIA Holdings’ (ICLR) better-than-expected Q2 earnings report, w...
07-28 22:54
IQVIA Holdings shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.
IQVIA Holdings shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.
07-28 21:05
财报速睇 | 艾昆纬 2026财年Q2营收43.68亿美元，同比增长8.7%；归母净利润2.56亿美元，同比下滑3.8%
华盛资讯7月28日讯，艾昆纬公布2026财年Q2业绩，公司Q2营收43.68亿美元，同比增长8.7%，归母净利润2.56亿美元，同比下滑3.8%。
07-28 19:22
